Sciensus names Christian Tucat as Chief Executive Officer

With the appointment of Christian Tucat as CEO, Sciensus aims to leverage insights and expand its global reach in delivering lifesaving drugs and therapies.

Regeneron aims to stop muscle loss with combination treatment approach in obesity

Regeneron reiterated its plans to jump into the weight loss race in 2024, expecting to start testing a combination of its muscle-preserving drugs with semaglutide,

February 3, 2024

Sino Biological finalizes the acquisition of SignalChem Biotech, strengthening global presence and expanding product portfolio

April 29, 2024

Key transport systems fuel rapid E. coli growth in UTIs

Through a quirk of anatomy, women are especially prone to urinary tract infections, with almost half dealing with one at some point in their lives.

May 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.